4CMenB and MenACWY-CRM Vaccines Co-Administered Safely in Adolescents
A phase 3b study demonstrated that co-administration of 4CMenB and MenACWY-CRM in adolescents is safe and immunogenic.
Company
Pharmaceutical intelligence for MenACWY-CRM with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.